Epribenz 50mg Injection
Marketer
Admac Pharma Ltd
Salt Composition
Epirubicin (50mg)
Overview Epribenz 50mg Injection
Epribenz 50mg injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to prescribed instructions is crucial; misuse can cause severe adverse reactions. Therapeutic effects might not be immediately apparent; discontinue only under medical guidance. Epribenz reduces contraceptive efficacy; reliable birth control is advised for both partners during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and skin rashes. Reduced blood cell counts increase infection risk, potentially severe. Regular blood tests monitor blood cell levels, kidney, liver, and heart function. Disclose any liver or heart conditions, and all other medications, to your doctor before commencing treatment, as interactions may affect efficacy. Report pregnancy or breastfeeding.
Primary Ingredients of Epribenz 50mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Epribenz 50mg Injection
Malignancy
Major Benefits of Epribenz 50mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Epribenz 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epribenz 50mg Injection:
Administering this medication will be performed by your physician or registered nurse; self-medication is strictly prohibited.
How Epribenz 50mg Injection works:
Epribenz 50mg Injection is a cancer therapeutic agent. Its mechanism of action involves inhibiting topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, ultimately hindering breast cancer cell proliferation and inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining Epribenz 50mg Injection with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Epribenz 50mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits clearly outweigh the known dangers. Always seek medical advice before using this medication.
Breast feedingUNSAFE
Administration of Epribenz 50mg Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.
DrivingUNSAFE
The use of Epribenz 50mg Injection may result in adverse reactions, including nausea and vomiting, potentially affecting driving ability. These episodes of nausea and vomiting could temporarily compromise safe driving.
KidneySAFE IF PRESCRIBED
The use of Epribenz 50mg Injection in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages should be evaluated by a physician.
LiverCAUTION
Patients with liver impairment should use Epribenz 50mg Injection cautiously, potentially requiring a modified dosage. Consult a physician for guidance. Epribenz 50mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Epribenz 50mg Injection :
NA
Facts to Know About Epribenz 50mg Injection
Label | Value |
---|---|
Chemical Type | Anthracycline Analog |
Developing Habits | No. |
Type of Therapy | Cancer Medications |
Actions | Cytotoxic alkaloids |